BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2012
View Archived Issues
Chaperone Therapeutics receives grant for Parkinson's research
Read More
Estrogen receptor PET imaging improves diagnostic understanding of patients with breast cancer
Read More
VT-464 reduces tumor growth in prostate cancer model
Read More
ARN-509 is well tolerated in phase I/II study
Read More
Novel lysophospholipid S1P1 receptor agonists disclosed by Merck Serono
Read More
Affibody and Creative Antibiotics to collaborate on targeted antibiotics
Read More
Recruitment begins in phase I SGT-94 gene therapy study
Read More
Agennix halts phase II/III talactoferrin trial in severe sepsis
Read More
Scientists at Allergan prepare new prostanoid receptor antagonists
Read More
U.S. study uncovers new therapeutic target for breast cancer
Read More
Novel antiviral agents disclosed by Gilead Sciences
Read More
D-Pharm receives recommendation to stop recruitment in MACSI stroke study
Read More
Intercell reports on two phase III studies of Ixiaro/Jespect
Read More
Reviva Pharmaceuticals synthesizes new monoamine transporter inhibitors
Read More
Researchers at Ironwood Pharmaceuticals patent novel GCS activators
Read More
FDA approves Janumet XR for type 2 diabetes
Read More
Compugen reports data on therapeutic potential of CGEN-15001T
Read More
Study investigates cause of FSHD and identifies candidate FSHD biomarkers
Read More
Japanese company synthesizes new neutrophil elastase inhibitors
Read More
Dynavax reports on Heplisav pre-BLA meeting with FDA
Read More
StemCells receives FDA clearance to conduct study in macular degeneration
Read More
Nuvo Research launches Synera in U.S.
Read More
Japanese approval for new formulation of Fosrenol
Read More
Critical Outcome Technologies readies oral formulation candidates for phase I cancer study
Read More
Inhibition of iron accumulation in brain can prevent neurodegenerative disorders
Read More
Threshold Pharmaceuticals and Merck KGaA enter global agreement for hypoxia-targeted TH-302
Read More